A late stage German ovarian cancer patient, who was given months to live, in 1987 was injected with a then-experimental bio tech drug. The monoclonal antibody was being used to track tumors in the ovarian cancer patients body. Instead, it may lead to a breakthrough treatment for ovarian cancer patients.
In a recent internet news website article, University of Alberta Professor Emeritus Antoine Noujaim told StockInterview.com, “There is the very origin ...
Satisfied Users & 
Approved Press Releases
